Ascorbic acid and rates of cognitive decline in Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 16, Issue 1, 2009, Pages 93-98

  Bowman, Gene L ^a,e   Dodge, Hiroko ^a,b   Frei, Balz ^d   Calabrese, Carlo ^c   Oken, Barry S ^a   Kaye, Jeffrey A ^a   Quinn, Joseph F ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON STATE UNIVERSITY   (United States)

^c OREGON STATE UNIVERSITY   (United States)

^d National College of Natural Medicine   (United States)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Albumin; Alzheimer's disease; Antioxidants; Ascorbic acid; Blood brain barrier; Cerebrospinal fluid; Cognitive decline; Vitamin C

Indexed keywords

ALBUMIN; ASCORBIC ACID; BIOLOGICAL MARKER;

AGED; ALZHEIMER DISEASE; ARTICLE; ARTIFACT; BLOOD BRAIN BARRIER; BLOOD SAMPLING; BRAIN LEVEL; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CLINICAL ASSESSMENT; FEMALE; HUMAN; HYPOTHESIS; MALE; MENTAL DETERIORATION; MINI MENTAL STATE EXAMINATION; NERVE DEGENERATION; PREDICTOR VARIABLE; PRIORITY JOURNAL; REGRESSION ANALYSIS; VITAMIN BLOOD LEVEL;

EID: 58849157247     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2009-0923     Document Type: Article

References (30)

1. Markesbery WR, Carney JM (1999) Oxidative alterations in Alzheimer's disease. Brain Pathol 9, 133-146.
2. Lovell MA, Markesbery WR(2007) Oxidative damage in mild cognitive impairment and early Alzheimer's disease. J Neurosci Res 85, 3036-3040.
3. Bourdel-Marchasson I, Delmas-Beauvieux MC, Peuchant E, Richard-Harston S, Decamps A, Reignier B, Emeriau JP, Rainfray M (2001) Antioxidant defences and oxidative stress markers in erythrocytes and plasma from normally nourished elderly Alzheimer patients. Age Ageing 30, 235-241.
4. Butterfield DA, Griffin S, Munch G, Pasinetti GM (2002) Amyloid beta-peptide and amyloid pathology are central to the oxidative stress and inflammatory cascades under which Alzheimer's disease brain exists. J Alzheimers Dis 4, 193-201.
5. Engelhart MJ, Geerlings MI, Ruitenberg A, van Swieten JC, Hofman A, Witteman JC, Breteler MM (2002) Dietary intake of antioxidants and risk of Alzheimer disease. JAMA 287, 3223-3229.
6. Martin A, Cherubini A, Andres-Lacueva C, Paniagua M, Joseph J (2002) Effects of fruits and vegetables on levels of vitamins E and C in the brain and their association with cognitive performance. J Nutr Health Aging 6, 392-404.
7. Meydani M (2001) Antioxidants and cognitive function. Nutr Rev 59, S75-80; discussion S80-72.
8. Resende R, Moreira PI, Proenca T, Deshpande A, Busciglio J, Pereira C, Oliveira CR (2008) Brain oxidative stress in a triple-transgenic mouse model of Alzheimer disease. Free Radic Biol Med 44, 2051-2057.
9. Rice ME (2000) Ascorbate regulation and its neuroprotective role in the brain. Trends Neurosci 23, 209-216.
10. Floyd RA, Hensley K (2002) Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases. Neurobiol Aging 23, 795-807.
11. Drew KL, Toien O, Rivera PM, Smith MA, Perry G, Rice ME (2002) Role of the antioxidant ascorbate in hibernation and warming from hibernation. Comp Biochem Physiol C Toxicol Pharmacol 133, 483-492.
12. Quinn J, Suh J, Moore MM, Kaye J, Frei B (2003) Antioxidants in Alzheimer's disease-vitamin C delivery to a demanding brain. J Alzheimers Dis 5, 309-313.
13. Davson H, Segal HB (1996) Physiology of the CSF and Blood-Brain Barriers, CRC, Boca Raton.
14. Spector R, Johanson C (2006) Micronutrient and urate transport in choroid plexus and kidney: implications for drug therapy. Pharm Res 23, 2515-2524.
15. Tibbling G, Link H, Ohman S (1977) Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values. Scand J Clin Lab Invest 37, 385-390.
16. Reiber H (1994) Flow rate of cerebrospinal fluid (CSF) - a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases. J Neurol Sci 122, 189-203.
17. Bowman GL, Quinn JF (2008) Alzheimer's disease and the blood-brain barrier: past, present and future. Aging Health 4, 47-57.
18. Reiber H, Peter JB (2001) Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs. J Neurol Sci 184, 101-122.
19. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944.
20. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12, 189-198.
21. Dooneief G, Marder K, Tang MX, Stern Y (1996) The Clinical Dementia Rating scale: community-based validation of "profound" and "terminal" stages. Neurology 46, 1746-1749.
22. Rosen WG, Mohs RC, Davis KL (1984) A new rating scale for Alzheimer's disease. Am J Psychiatry 141, 1356-1364.
23. Moroney JT, Bagiella E, Desmond DW, Hachinski VC, Molsa PK, Gustafson L, Brun A, Fischer P, Erkinjuntti T, Rosen W, Paik MC, Tatemichi TK (1997) Meta-analysis of the Hachinski Ischemic Score in pathologically verified dementias. Neurology 49, 1096-1105.
24. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, Leirer VO (1982) Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 17, 37-49.
25. Frei B, England L, Ames BN (1989) Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci U S A 86, 6377-6381.
26. Bowman GL, Kaye JA, Moore M, Waichunas D, Carlson NE, Quinn JF (2007) Blood-brain barrier impairment in Alzheimer disease: stability and functional significance. Neurology 68, 1809-1814.
27. Greenberg SM, Briggs ME, Hyman BT, Kokoris GJ, Takis C, Kanter DS, Kase CS, Pessin MS (1996) Apolipoprotein E epsilon 4 is associated with the presence and earlier onset of hemorrhage in cerebral amyloid angiopathy. Stroke 27, 1333-1337.
28. Spector R (1977) Vitamin homeostasis in the central nervous system. N Engl J Med 296, 1393-1398.
29. Reiber H, Ruff M, Uhr M (1993) Ascorbate concentration in human cerebrospinal fluid (CSF) and serum. Intrathecal accumulation and CSF flow rate. Clin Chim Acta 217, 163-173.
30. Paraskevas GP, Kapaki E, Libitaki G, Zournas C, Segditsa I, Papageorgiou C (1997) Ascorbate in healthy subjects, amyotrophic lateral sclerosis and Alzheimer's disease. Acta Neurol Scand 96, 88-90.